Akzo Nobel N.V.
AKZA.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €9,895 | €12,587 | €10,931 | €17,849 |
| - Cash | €1,302 | €1,513 | €1,450 | €1,152 |
| + Debt | €5,368 | €5,563 | €5,875 | €3,550 |
| Enterprise Value | €13,961 | €16,637 | €15,356 | €20,247 |
| Revenue | €10,711 | €10,668 | €10,846 | €9,587 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Gross Profit | €4,337 | €4,234 | €3,923 | €3,855 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| EBITDA | €1,399 | €1,413 | €1,052 | €1,530 |
| % Margin | 13.1% | 13.2% | 9.7% | 16% |
| Net Income | €542 | €442 | €352 | €829 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| % Growth | 22.5% | 28.4% | -54.9% | – |
| Operating Cash Flow | €673 | €1,120 | €263 | €605 |
| Capital Expenditures | -€306 | -€286 | -€292 | -€288 |
| Free Cash Flow | €367 | €840 | -€29 | €317 |